You are here

lupus

Aria Pharmaceuticals Secures Six Provisional Patents for Pipeline Candidates

BioSpace

Wed, 08/31/22 - 10:25 am

Aria Pharmaceuticals

idiopathic pulmonary fibrosis

chronic kidney disease

Bristol Myers Squibb, with new positive lupus data in hand, readies TYK2 inhibitor for final test

Fierce Biotech

Wed, 06/1/22 - 09:48 am

Bristol Myers Squibb

deucravacitinib

Seres, Vera Notch Weekend Wins in C.Diff, Lupus Trials

BioSpace

Mon, 05/23/22 - 10:22 am

Seres Therapeutics

clinical trials

Vera Therapeutics

Eli Lilly, Incyte axe Olumiant in lupus amid eczema stalemate at FDA

Fierce Pharma

Fri, 01/28/22 - 11:47 am

Idorsia sets itself up for failure

EP Vantage

Mon, 11/1/21 - 10:57 pm

clinical trials

AstraZeneca's launch plan for first-in-class lupus med Saphnelo centers on patient-designed support program

Fierce Pharma

Tue, 08/3/21 - 11:13 am

patient advocacy groups

AstraZeneca nabs FDA nod to challenge GSK's Benlysta with first-in-class lupus drug Saphnelo

Fierce Pharma

Mon, 08/2/21 - 11:08 am

systemic lupus erythematosus

GlaxoSmithKline debuts DTC campaign for lupus med Benlysta as it looks to cement category lead

Fierce Pharma

Tue, 07/27/21 - 04:24 pm

DTC advertising

Biogen (BIIB) Initiates Late-Stage Study on Lupus Candidate

Yahoo/Zacks.com

Mon, 06/21/21 - 10:54 am

clinical trials

Progentec’s Novel Blood Test Predicts Lupus Flares Up to 12 Weeks Before They Occur

BioSpace

Mon, 09/21/20 - 10:51 am

Progentec Diagnostics

J&J scraps late-stage study testing Stelara for lupus

Reuters

Sat, 06/27/20 - 11:40 pm

clinical trials

AbbVie beefs up the immunology pipeline, betting up to $865M on a PhII-ready drug — and fueling a biotech stock frenzy

Endpoints

Thu, 06/18/20 - 10:55 am

Alpine Immune Sciences

How a Seattle Genetics cancer drug could help lupus patients with kidney damage

Fierce Biotech

Thu, 04/9/20 - 10:35 am

Seattle Genetics

AstraZeneca lupus drug shows potential, but it may not be enough for FDA

Biopharma Dive

Thu, 12/19/19 - 01:05 pm

GlaxoSmithKline's Benlysta eyes lupus sales boost after kidney trial win

Fierce Pharma

Wed, 12/18/19 - 10:54 am

'Positive surprise' for Biogen in lupus, but all eyes on CTAD data this week

Fierce Biotech

Tue, 12/3/19 - 10:20 pm

Amgen clinical trials

AstraZeneca plans 2020 filing for anifrolumab in lupus

Fierce Biotech

Tue, 11/12/19 - 10:25 am

Roche steers Gazyva into a new PhIII program after combo shows promise in lupus nephritis study

Endpoints

Mon, 11/11/19 - 11:04 am

monoclonal antibodies

clinical trials

Gilead’s filgotinib fails midphase tests in lupus, Sjogren's

Fierce Biotech

Fri, 10/25/19 - 10:39 am

Gilead Sciences

Sjögren’s syndrome

clinical trials

Upcoming events – Sage targets depression and Biogen aims for lupus

EP Vantage

Fri, 10/4/19 - 10:03 am

SAGE Therapeutics

major depressive disorder

Pages